Los Angeles Capital Management LLC Forma Therapeutics Holdings, Inc. Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022
SELL
$8.34 - $14.69 $253,369 - $446,282
-30,380 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$13.6 - $24.89 $166,600 - $304,902
12,250 Added 67.57%
30,380 $432,000
Q3 2021

Nov 08, 2021
SELL
$21.22 - $25.7 $33,315 - $40,349
-1,570 Reduced 7.97%
18,130 $420,000
Q2 2021

Aug 05, 2021
SELL
$22.86 - $30.95 $16,002 - $21,665
-700 Reduced 3.43%
19,700 $490,000
Q1 2021

May 05, 2021
BUY
$24.58 - $42.82 $501,431 - $873,528
20,400 New
20,400 $571,000

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email